The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
The post-acute phase of SARS-CoV-2 infection was investigated in rhesus (Macaca mulatta) and cynomolgus macaques (Macaca fascicularis). During the acute phase of infection, SARS-CoV-2 was shed via the nose and throat, and viral RNA was occasionally detected in feces. This phase coincided with a transient change in systemic immune activation. Even after the alleged resolution of the infection, computed tomography (CT) and positron emission tomography (PET)-CT revealed pulmonary lesions and activated tracheobronchial lymph nodes in all animals. Post-mortem histological examination of the lung tissue revealed mostly marginal or resolving minimal lesions that were indicative of SARS-CoV-2 infection. Evidence for SARS-CoV-2-induced histopathology was also found in extrapulmonary tissue samples, such as conjunctiva, cervical, and mesenteric lymph nodes. However, 5–6 weeks after SARS-CoV-2 exposure, upon necropsy, viral RNA was still detectable in a wide range of tissue samples in 50% of the macaques and included amongst others the heart, the respiratory tract and surrounding lymph nodes, salivary gland, and conjunctiva. Subgenomic messenger RNA was detected in the lungs and tracheobronchial lymph nodes, indicative of ongoing virus replication during the post-acute phase. These results could be relevant for understanding the long-term consequences of COVID-19 in humans.
Article activity feed
-
-
SciScore for 10.1101/2020.11.05.369413: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Upon positive advice by the independent ethics committee (DEC-BPRC) the competent authorities (CCD, Central Committee for Animal Experiments) issued a project license (license AVD5020020209404).
IACUC: Upon positive advice by the independent ethics committee (DEC-BPRC) the competent authorities (CCD, Central Committee for Animal Experiments) issued a project license (license AVD5020020209404).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources To detect macaque-IgM, the same protocol was followed, but the secondary … SciScore for 10.1101/2020.11.05.369413: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Upon positive advice by the independent ethics committee (DEC-BPRC) the competent authorities (CCD, Central Committee for Animal Experiments) issued a project license (license AVD5020020209404).
IACUC: Upon positive advice by the independent ethics committee (DEC-BPRC) the competent authorities (CCD, Central Committee for Animal Experiments) issued a project license (license AVD5020020209404).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources To detect macaque-IgM, the same protocol was followed, but the secondary antibody used was an anti-Monkey IgM (μ-chain specific)-Peroxidase antibody produced in goat (Sigma-Aldrich, Merck KGaA, MI, USA) at 1:5000 dilution. anti-Monkey IgMsuggested: Noneμ-chain specific)-Peroxidasesuggested: NoneExperimental Models: Cell Lines Sentences Resources This strain was isolated from a patient who traveled from China to Germany, and an aliquot of a Vero E6 cell culture was made available through the European Virus Archive-Global (EVAg). Vero E6suggested: RRID:CVCL_XD71)Software and Algorithms Sentences Resources Ethics and Biosafety Statement: All housing and animal care procedures took place at the Biomedical Primate Research Centre (BPRC) in Rijswijk, the Netherlands. BPRCsuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
-